Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Apr-23 6:29 PM View:  | Agro Albert Chief Medical Officer | Gri Bio, Inc. (GRI) | 21-Apr-23 | Grant | 172,189 | -- | -- | 100% 0 to 172.19K | |
| 24-Apr-23 6:30 PM View: | Hertz Walter Marc Chief Executive Officer Director 10% Owner | Gri Bio, Inc. (GRI) | 21-Apr-23 | Grant | 385,510 | -- | -- | 100% 0 to 385.51K | |
| 24-Apr-23 6:29 PM View: | Chaturvedi Vipin Chief Scientific Officer | Gri Bio, Inc. (GRI) | 21-Apr-23 | Grant | 172,189 | -- | -- | 100% 0 to 172.19K | |
| 15-Dec-22 4:26 PM View: | Thorell Marella Director | Gri Bio, Inc. (GRI) | 13-Dec-22 | Disposition (other) | 28,517 | -- | -- | (75%) 38.02K to 9.51K | |
| 06-Jul-22 2:03 PM View: | Thorell Marella Director | Gri Bio, Inc. (GRI) | 01-Jul-22 | Grant | 38,023 | -- | -- | 100% 0 to 38.02K | |
| 04-Jun-21 4:06 PM View: | Kelly Leanne M. Chief Financial Officer | Gri Bio, Inc. (GRI) | 04-Jun-21 | Market Purchase | 1,508 | $4.08 | $6,152.64 | 32% 4.74K to 6.25K | 0% |
| 04-Jun-21 4:06 PM View: | Kelly Leanne M. Chief Financial Officer | Gri Bio, Inc. (GRI) | 03-Jun-21 | Market Purchase | 1,085 | $4.05 | $4,394.25 | 30% 3.66K to 4.74K | < 1% |
| 04-Jun-21 4:06 PM View: | Kelly Leanne M. Chief Financial Officer | Gri Bio, Inc. (GRI) | 02-Jun-21 | Market Purchase | 3,657 | $4.00 | $14,628.00 | 100% 0 to 3.66K | 2% |
| 27-May-21 8:37 PM View: | Payne Joseph E Director | Gri Bio, Inc. (GRI) | 26-May-21 | Market Purchase | 6,800 | $4.50 | $30,600.00 | < 1% 854.45K to 861.25K | (3%) |
| 27-May-21 8:37 PM View: | Payne Joseph E Director | Gri Bio, Inc. (GRI) | 25-May-21 | Market Purchase | 10,700 | $3.85 | $41,195.00 | 1% 843.75K to 854.45K | 13% |
| 12-Feb-21 6:02 PM View: | Salmon Pharma Gmbh 10% Owner | Gri Bio, Inc. (GRI) | 12-Feb-21 | Acquisition (other) | 47,063 | $6.40 | $301,203.00 | 100% 0 to 47.06K | |
| 12-Feb-21 6:02 PM View: | Ammer Richard Director | Gri Bio, Inc. (GRI) | 12-Feb-21 | Acquisition (other) Duplicate | 47,063 | $6.40 | $301,203.00 | 100% 0 to 47.06K | |
| 12-Feb-21 6:00 PM View: | Baker David Charles Chief Executive Officer Director | Gri Bio, Inc. (GRI) | 12-Feb-21 | Acquisition (other) | 7,843 | $6.40 | $50,195.20 | 100% 0 to 7.84K | |
| 12-Feb-21 6:00 PM View: | Baker David Charles Chief Executive Officer Director | Gri Bio, Inc. (GRI) | 12-Feb-21 | Market Purchase | 1,000 | $8.00 | $8,000.00 | 13% 7.84K to 8.84K |
